- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Phenylketonuria (PKU)
- Meeting Date: July 2019
- Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)
Glycomacropeptide formula with docosahexaenoic acid with low phenylalanine – July 2019
Glycomacropeptide formula with docosahexaenoic acid with low phenylalanine: Oral liquid 250 mL, 18; PKU GMPro LQ®
Last updated
1 November 2019